Tower Research Capital LLC (Trc) Cellectis S.A. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.58 - $2.86 $104 - $188	66 Added 146.67%	111 $0
Q2 2023 Aug 14, 2023	BUY	$1.72 - $2.12 $77 - $95	45 New	45 $0
Q4 2022 Feb 10, 2023	BUY	$1.85 - $2.6 $35,705 - $50,180	19,300 Added 273.29%	26,362 $56,000
Q3 2022 Nov 10, 2022	BUY	$2.29 - $4.08 $1,600 - $2,851	699 Added 10.99%	7,062 $16,000
Q2 2022 Aug 15, 2022	SELL	$2.39 - $4.93 $4,507 - $9,297	-1,886 Reduced 22.86%	6,363 $18,000
Q1 2022 May 12, 2022	BUY	$3.45 - $8.77 $24,774 - $62,977	7,181 Added 672.38%	8,249 $37,000
Q4 2021 Feb 14, 2022	SELL	$8.01 - $12.84 $7,537 - $12,082	-941 Reduced 46.84%	1,068 $9,000
Q3 2021 Nov 15, 2021	SELL	$11.94 - $16.09 $76,416 - $102,976	-6,400 Reduced 76.11%	2,009 $25,000
Q2 2021 Aug 16, 2021	SELL	$14.36 - $20.93 $4,652 - $6,781	-324 Reduced 3.71%	8,409 $130,000
Q1 2021 May 17, 2021	BUY	$18.19 - $33.25 $158,562 - $289,840	8,717 Added 54481.25%	8,733 $176,000
Q4 2020 Feb 16, 2021	SELL	$15.87 - $31.64 $10,696 - $21,325	-674 Reduced 97.68%	16 $0
Q3 2020 Nov 16, 2020	SELL	$15.7 - $20.84 $32,090 - $42,596	-2,044 Reduced 74.76%	690 $13,000
Q2 2020 Aug 13, 2020	BUY	$8.21 - $21.02 $9,055 - $23,185	1,103 Added 67.63%	2,734 $49,000
Q1 2020 May 15, 2020	BUY	$7.81 - $18.82 $11,543 - $27,815	1,478 Added 966.01%	1,631 $15,000
Q4 2019 Feb 07, 2020	SELL	$9.73 - $19.31 $3,609 - $7,164	-371 Reduced 70.8%	153 $3,000
Q3 2019 Nov 05, 2019	BUY	$10.15 - $16.89 $3,999 - $6,654	394 Added 303.08%	524 $5,000
Q2 2019 Aug 13, 2019	SELL	$14.6 - $20.6 $78,168 - $110,292	-5,354 Reduced 97.63%	130 $2,000
Q1 2019 May 14, 2019	BUY	$15.53 - $19.75 $54,960 - $69,895	3,539 Added 181.95%	5,484 $100,000
Q4 2018 Feb 14, 2019	SELL	$15.58 - $28.41 $17,262 - $31,478	-1,108 Reduced 36.29%	1,945 $32,000
Q3 2018 Nov 13, 2018	BUY	$25.99 - $30.6 $74,825 - $88,097	2,879 Added 1654.6%	3,053 $86,000
Q2 2018 Aug 15, 2018	SELL	$27.78 - $38.53 $16,140 - $22,385	-581 Reduced 76.95%	174 $5,000
Q1 2018 May 15, 2018	SELL	$27.78 - $35.19 $22,807 - $28,890	-821 Reduced 52.09%	755 $24,000
Q4 2017 Feb 09, 2018	BUY	$23.33 - $35.01 $36,768 - $55,175	1,576	1,576 $46,000

Others Institutions Holding CLLS

# of Institutions

Shares Held

10.8M

Call Options Held

5.9K

Put Options Held

1.4K

Long Focus Capital Management, LLC San Juan, PR

4.62M
Shares

$7.2 Million
0.36% of portfolio
Capital International Investors Los Angeles, CA

1.85M
Shares

$2.88 Million
0.0% of portfolio
Credit Suisse Ag Zurich, V8

1.44M
Shares

$2.24 Million
0.0% of portfolio
Ubs Asset Management Americas Inc Chicago, IL

1.44M
Shares

$2.24 Million
0.0% of portfolio
Baillie Gifford & CO

694K
Shares

$1.08 Million
0.0% of portfolio

View Full List

About Cellectis S.A.

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $71M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

More about CLLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account